STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Colgate-Palmolive (NYSE: CL) director awarded new stock and options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Colgate-Palmolive director Martina Hundmejean received equity awards as part of her annual compensation. She was granted 2,075 shares of Common Stock at no cost, credited to a stock unit account under the company’s incentive compensation plan, bringing her direct holdings to 16,206 shares.

She also received a stock option for 2,424 shares of Common Stock with an exercise price of $86.74 per share. The option vests in equal annual installments over three years, starting on the first anniversary of the May 11, 2026 grant date. These are compensation-related grants, not open-market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider HUNDMEJEAN MARTINA
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,424 $0.00 --
Grant/Award Common Stock 2,075 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,424 shares (Direct, null); Common Stock — 16,206 shares (Direct, null)
Footnotes (1)
  1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Annual director stock option grant under the issuer's incentive compensation plan. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Stock grant size 2,075 shares Annual director stock grant on May 11, 2026
Shares held after grant 16,206 shares Common Stock directly held after May 11, 2026 award
Option grant size 2,424 options Stock Option (Right to Buy) granted May 11, 2026
Option exercise price $86.74 per share Exercise price for 2,424-share stock option
Option expiration May 11, 2034 Expiration date of stock option grant
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
Annual director stock option grant financial
"Annual director stock option grant under the issuer's incentive compensation plan"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HUNDMEJEAN MARTINA
(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NEW YORK 10022
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026A(1)2,075A$0.000016,206D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$86.7405/11/2026A(2)2,424 (3)05/11/2034Common Stock2,424$0.00002,424D
Explanation of Responses:
1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
2. Annual director stock option grant under the issuer's incentive compensation plan.
3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Colgate-Palmolive (CL) director Martina Hundmejean report in this Form 4?

Director Martina Hundmejean reported receiving equity compensation awards, not open-market trades. She was granted 2,075 shares of Common Stock and a stock option covering 2,424 shares, both under Colgate-Palmolive’s incentive compensation plan as part of her annual director compensation.

How many Colgate-Palmolive (CL) shares does Martina Hundmejean hold after the grants?

After the latest grant, Martina Hundmejean directly holds 16,206 shares of Colgate-Palmolive Common Stock. This reflects her updated ownership position following the award of 2,075 additional shares credited to a stock unit account under the company’s incentive compensation plan.

What are the terms of Martina Hundmejean’s new Colgate-Palmolive (CL) stock option?

She received a stock option for 2,424 shares of Colgate-Palmolive Common Stock with an exercise price of $86.74 per share. The option vests in three equal annual installments beginning on the first anniversary of the May 11, 2026 grant date, according to the disclosure.

Is Martina Hundmejean buying or selling Colgate-Palmolive (CL) stock in this filing?

The filing shows compensation-related acquisitions, not open-market buying or selling. Martina Hundmejean received 2,075 shares and a 2,424-share stock option as annual director grants under Colgate-Palmolive’s incentive compensation plan, rather than executing discretionary purchases or sales in the market.

How is the annual director stock grant for Colgate-Palmolive (CL) structured?

The annual director stock grant is credited to a stock unit account under Colgate-Palmolive’s incentive compensation plan. In this case, Martina Hundmejean received 2,075 Common Stock units plus a separate 2,424-share stock option grant as part of her annual director compensation package.

When do Martina Hundmejean’s new Colgate-Palmolive (CL) options become exercisable?

The stock option becomes exercisable in equal annual installments over three years. Vesting starts on the first anniversary of the May 11, 2026 grant date, meaning portions of the 2,424-share option will vest each year over that three-year period.